[Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
D000328:Adult; D002741:Chlorotrianisene / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D008598:Menstruation / Q000187:drug effects; D049590:Postpartum Period; D011247:Pregnancy; D014599:Uterus / Q000187:drug effects
D004873:Ergolines; D002741:Chlorotrianisene
Prévention de la lactation post partum avec un nouveau dérivé de l'ergot: la 2-Br-alpha-ergocryptine ou CB-154. Comparaison avec le chlorotrianisen